Prévalence de la pneumopathie à Pneumocystis Jiroveci au cours des déficits immunitaires héréditaires observés en Tunisie
暂无分享,去创建一个
[1] W. Reith,et al. Regulation of MHC class II expression, a unique regulatory system identified by the study of a primary immunodeficiency disease. , 2006, Tissue antigens.
[2] A. Limper,et al. Pneumocystis pneumonia. , 2004, The New England journal of medicine.
[3] R. Geha,et al. The X-Linked Hyper-IgM Syndrome: Clinical and Immunologic Features of 79 Patients , 2003, Medicine.
[4] M. Barbouche,et al. [The hyper-IgM syndrome: 13 observations]. , 2003, Presse medicale.
[5] Kelvin P Lee,et al. Evidence for the requirement of T cell costimulation in the pathogenesis of natural Pneumocystis carinii pulmonary infection. , 2002, Microbial pathogenesis.
[6] A. Kemp,et al. Pneumocystis carinii pneumonia in an infant with transient hypogammaglobulinaemia of infancy , 2002, Archives of disease in childhood.
[7] K. Sepkowitz. Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] M. Béji,et al. Fréquence des pneumopathies à pneumocystis carinii chez le sujet infecté par VIH en Tunisie , 2002 .
[9] W. Reith,et al. MHC class II deficiency: a disease of gene regulation. , 2001, Medicine.
[10] J. Berrington,et al. Unsuspected Pneumocystis cariniipneumonia at presentation of severe primary immunodeficiency , 2000, Archives of disease in childhood.
[11] P. Walzer. Immunological Features of Pneumocystis carinii Infection in Humans , 1999, Clinical Diagnostic Laboratory Immunology.
[12] J. Beck,et al. Lymphocytes in host defense against Pneumocystis carinii. , 1998, Seminars in respiratory infections.
[13] K. Dellagi,et al. Déficit immunitaire primitif par défaut d'expression des antigènes HLA de classe II: neuf observations tunisiennes , 1998 .
[14] S. Belhadj,et al. La pneumocystose : maladie peu fréquente en Tunisie ? , 1998 .
[15] M. Lepore,et al. Pneumocystis carinii pneumonia in an infant with X-linked agammaglobulinemia. , 1998, The Journal of allergy and clinical immunology.
[16] K. Dellagi,et al. Les dficits immunitaires primitifs en Tunisie: tude de 152 cas , 1997 .
[17] J. Standing,et al. The role of alveolar macrophages in Pneumocystis carinii degradation and clearance from the lung. , 1997, The Journal of clinical investigation.
[18] B. Garvy,et al. Role of gamma interferon in the host immune and inflammatory responses to Pneumocystis carinii infection , 1997, Infection and immunity.
[19] A. Yapi,et al. [Pulmonary complications of human immunodeficiency virus infection in sub-Saharan Africa]. , 1997, Revue de pneumologie clinique.
[20] C. Hennequin. [Prevention of parasitic infections (excluding toxoplasmosis) in immunocompromised patients]. , 1997, Annales de medecine interne.
[21] J. Kovacs,et al. Pneumocystis carinii in Africa: an emerging pathogen? , 1995, The Lancet.
[22] E. Chaker,et al. La pneumocystose pulmonaire en Tunisie. A propos de 6 cas , 1994 .
[23] A. Fischer,et al. Major histocompatibility complex class II deficiency: clinical manifestations, immunologic features, and outcome. , 1993, The Journal of pediatrics.
[24] T. Quinn,et al. Geographic variation in the humoral response to Pneumocystis carinii. , 1993, The Journal of infectious diseases.
[25] K. D. de Cock,et al. Pneumocystis carinii Pneumonia: An Uncommon Cause of Death in African Patients with Acquired Immunodeficiency Syndrome , 1992 .
[26] J. Smith,et al. Pneumocystis carinii, an opportunist in immunocompromised patients , 1991, Clinical Microbiology Reviews.
[27] B. Carme,et al. [Pneumocystis carinii pneumonia in patients with AIDS in the Congo]. , 1991, Revue de pneumologie clinique.
[28] J. Phair,et al. The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group. , 1990, The New England journal of medicine.
[29] W. Hughes. Pneumocystis Carinii Pneumonia * , 2001, Interstitial Lung Diseases in Children.